Adam Hochron

Allergan has made a name for itself in the treatment of many neurological and mental health conditions and continues to grow its portfolio. One of its newest offerings is cariprazine which they hope will be a powerful tool in the antipsychotic area.

What can a successful partnership at home mean for preventing alcohol abuse? According to one study that balance can mean the added ability to prevent a condition which can otherwise have a dramatic affect on their lives.

When wounded service members come home from war they have many areas of care that need to be addressed. Studies have shown that sexual health is an important part of the overall treatment picture.

The history of botulinum toxins dates back hundreds of years. What it can mean for the future of medicine and what conditions it can help in the future remains to be seen.

As with many parts of medicine guidelines are constantly being updated across a variety of specialties. The American Academy of Neurology recently released new guidance on how and when to use botulinum toxin in patient care.

As more states across the country legalize marijuana in a variety of forms the usefulness of cannabinoids as a treatment method for people with neuropathic pain remains a question that many studies have explored.

As the risk of a stroke increases with age so does the importance of monitoring patients over the course of their later years.

As more is learned about epilepsy and new treatment methods are introduced to the market there is reason to be optimistic for patients while doctors work to provide the best care possible on an individual basis.

Previous literature has shown a potential challenge for women with epilepsy becoming pregnant a recent study showed that may not be the case after all.

Even if patients could benefit from treatment specialized epilepsy centers they may not know about the care they could receive for a variety of reasons.

Many patients diagnosed with epilepsy need specialized treatments to help manage their symptoms. While people may associate epilepsy centers with surgical procedures they can also provide other benefits as well.

Status epilepticus can be one of the most debilitating and hardest to treat neurological conditions. A potential new medication aims to help this patient population through a variety of delivery methods under development.

Whether it is learning from the military or finding consensus among the governing bodies of youth and scholastic sports there are steps that can be taken to make them safe and help limit the risk of injuries and concussions.

As contact sports come under the microscope to ensure the health and safety of players of all ages there remains a lot of work that can be done to make a level and fair playing field for everyone involved.

The issue of concussions and potential brain damage has made considerable headlines in recent years. What the cause and diagnosis of these issues are remain to be determined.

With a unique delivery method alemtuzumab, also known as Lemtrada has proven to be an effective treatment option for multiple sclerosis. While careful monitoring is required new data has shown benefits for the right patient population.

As more research is collected about Tecfidera's usage since clinical trials and approval there continue to be signs that it can be a good treatment option for patients with multiple sclerosis, especially in the earliest stages.

Technology has many uses in modern life. Recent research looked at whether advanced games and other apps could help improve cognitive function in patients with multiple sclerosis.

Whether it is communicating with friends, loved ones, or their health care providers, being able to communicate effectively can help them feel better about their conditions which can help the overall treatment process.

It may seem obvious, but being able to effectively communicate to patients about their cardiovascular care can have a dramatic impact on treatment in the long run.

Despite recently approved medications showing improvement over previously used diet pills and other treatments there is still no medicinal cure for obesity and the best hope for patients in many cases is lifestyle changes.

The US Food and Drug Administration recently approved some new tools in the fight against obesity. While they provide some help for patients looking to lose weight there are also side effects which doctors and patients patients to consider.

Medical science and research has helped move many parts of cardiology from potentially fatal conditions to more chronic issues for patients and doctors to address. Cholesterol control is moving in that direction thanks to new advancements in medication and surgical options.

HDL and LDL may be the more well known components of a patient's cholesterol level but as researchers dig deeper new information is coming to light about very low-density lipoprotein or VLDL.

There are many ways patients can better manage their cholesterol than they could just a few years ago. Whether they are successful in those efforts and the role of doctors and medications in that process remains to be seen.

As the debate continues between good cholesterol and bad cholesterol researchers are looking for answers on how to help patients manage their cholesterol levels.

Even as technology improves to help patients dealing with cardiovascular disease, those responsible for the procedures also must consider providing treatment while weighing the costs of that work.

Since its inception nearly a decade ago the PARTNER trials have shown new opportunities for cardiovascular disease patients to receive treatment they may not have been candidates for before.

For a chronic condition like heart failure there are many factors that can help decide the effectiveness of their care. A recent debate looked at whether low salt diet would help in that effort.

As doctors have more tools to treat patients with high cholesterol the American College of Cardiology released a new consensus statement to give guidance on potential best practices for non-statin therapies like PCSK9 inhibitors.